ONCAlert | 2017 NANETS Symposium

Venetoclax for the Treatment of Elderly Patients With CLL

Jacqueline C. Barrientos, MD
Published Online:4:48 PM, Wed December 6, 2017

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses venetoclax (Venclexta) for the treatment of elderly patients with chronic lymphocytic leukemia (CLL). 
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.